Efrem Kamen, 10% Owner at Oncocyte Corp (OCX), bought 350,000 shares at $1.26 ($440K) on 2022-04-14, disclosed to the SEC on 2022-06-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.23 | 19,210 | $24K | 5.4% |
| 2 | $1.23 | 30,790 | $38K | 8.6% |
| 3 | $1.26 | 57,630 | $73K | 16.5% |
| 4 | $1.26 | 57,630 | $73K | 16.5% |
| 5 | $1.26 | 92,370 | $116K | 26.5% |
| 6 | $1.26 | 92,370 |
| $116K |
| 26.5% |
| Total | $1.26 avg | 350,000 | $440K | 100% |
| Filing → |
| GNLN | BUY | 2019-10-03 | $319K | — | Filing → |
| GNLN | BUY | 2019-10-02 | $34K | — | Filing → |